Skip to main content
Premium Trial:

Request an Annual Quote

Syapse, Sylvester Comprehensive Cancer Center Ink Precision Medicine Deal

NEW YORK (GenomeWeb) – Syapse has teamed with the Sylvester Comprehensive Cancer Center to launch a precision medicine initiative aimed at cancer patients in South Florida and throughout the Southeastern US, the partners announced today.

The cancer center will use Syapse's informatics platform, which is designed to centralize, organize, and present clinical and genomic data from multiple sources to help guide treatment decisions. Through the alliance, physicians at Sylvester — a part of the University of Miami Health System — will have access to clinical, molecular, treatment, and outcomes data to help match cancer patients to specific therapies.

"Matching a cancer patient with a certain treatment based on the cancer's molecular profile is among the most promising treatment options in this age of personalized medicine," Jonathan Trent, associate director of clinical research at Sylvester and University of Miami professor, said in a statement.

The deal marks the latest in a series that Syapse has signed for its precision medicine platform and software including ones with Intermountain Healthcare and the University of California, San Francisco.